Abstract
Over the last decade, the drug delivery industry has evolved to become a key
area in the development of value added pharmaceutical products. The global
market grew from $15bn to $40bn during 2000-2006 as companies increasingly
turned to drug delivery technologies as a means of expanding product
lifecycles, enhancing drug efficacy and maximizing revenues. Although the
market is still dominated by the oral drug delivery system, a number of novel
technologies are emerging across all systems of delivery. However, the pure
drug delivery company model is rapidly becoming extinct as leading players
attempt to consolidate their strategic opportunities by expanding their focus
towards manufacturing, a trend that is expected to accelerate over the next
five years. ' Leading Drug Delivery Companies and Technologies' is a new report
published by Business Insights that examines the current and future trends
that are shaping the drug delivery market and reviews the key emerging
technologies across major systems of drug delivery. This report identifies the
product portfolios and targeted therapeutic areas of leading drug delivery
companies in addition to assessing their technology platforms to provide
guidance over their applicability, regulatory implications and developmental
progress. This report also evaluates the opportunities and threats facing each
of the companies profiled and provides a comparative analysis of the growth
strategies used to facilitate successful deals and collaborations. Identify
key trends and developments in the global drug delivery market, assess the
performances and portfolios of leading drug delivery companies and benchmark
their most successful strategies.
View Cart
